U.S. regulators rejected Elon Musk’s bid to test brain chips in humans, citing safety risks

U.S. regulators rejected Elon Musk’s bid to test brain chips in humans, citing safety risks, per CNBC.

Such FDA rejections do not mean a company will ultimately fail to gain the agency’s human-testing approval. But it was rejected at least once in 2022, per Reuters.

"Innovation and safety are not an either-or scenario,” said Owen Faris, who helps oversee the FDA’s Office of Product Evaluation and Quality.

In Feb 9, the U.S. Department of Transportation said it was investigating Elon Musk's brain-implant company Neuralink over the potentially illegal movement of hazardous pathogens.

"We are conducting an investigation to ensure that Neuralink is in full compliance with federal regulations and keeping their workers and the public safe from potentially dangerous pathogens," the spokesperson said.

In December, Neuralink stated in six months, Musk's brain-chip-implant company plans to start implanting on humans.

Read more: https://unusualwhales.com/news/elon-musks-neuralink-plans-to-implant-coin-sized-chip-into-human-brains-in-six-months